Drug Policy

Psychedelics Policy Newsletter: States pursue psilocybin expansion, Trump administration denies drug fast-tracking, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — March 2026

Commentary by Gregory Ferenstein

Technology can help shift overdose prevention and response to more effective harm-reduction strategies

Commentary by Ben Scher and Layal Bou Harfouch

Virginia’s proposed cannabis labor peace mandate violates federal law

Testimony by Geoffrey Lawrence

U.S. v. Hemani: Federal ban on firearm possession by unlawful drug users violates the Second Amendment

Ohio should regulate kratom-related products for adult use instead of pursuing overly restrictive bans

Testimony by Madison Carlino

New Hampshire could expand access to psilocybin

Testimony by Madison Carlino and Kaitlyn Boecker

Cannabusiness lawsuit highlights need for Congress to clarify federal treatment of marijuana

Commentary by Geoffrey Lawrence

What is 7-OH and why did the FDA seize this potentially life-saving substance?

Commentary by Geoffrey Lawrence